The Effect of 6% Hydroxyethyl Starch 130/0.4 on Blood Loss and Coagulation in Patients Medicated With Antiplatelet Agents Prior to Off-Pump Coronary Bypass Graft Surgery

NCT01051206 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

106

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Occlusive Disease

Interventions

DRUG: 6% hydroxyethyl Stach 130/0.4

Sponsor

Yonsei University